Government Regulation No. 243 / 2015 Coll.
Government Regulation amending Government Regulation No. 463 / 2013 Coll., on substance lists
Valid
Regulation
Effective from 01.10.2015
Text versions:
01.10.2015
30.09.2015
243
GOVERNMENT REGULATION
of 14 September 2015
amending Government Regulation No 463 / 2013 Coll., on substance lists
The Government orders pursuant to § 44c (1) of Act No. 167 / 1998 Coll., on addictive substances and on the amendment of certain other laws, as amended by Act No. 273 / 2013 Coll.:
Annex No 4 to Government Regulation No 463 / 2013 Coll., on substance lists, reads as follows:
"Annex No 4 to Government Regulation No 463 / 2013 Coll.
List No 4 of psychotropic substances
| Mezinárodní nechráněný název (INN) v českém jazyce | Další mezinárodní nechráněný název nebo obecný název | Chemický název podle IUPAC | Poznámka |
|---|---|---|---|
| AH-7921 | 3,4-dichlor-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamid | ||
| AM-2201 | [1-(5-fluorpentyl)-1H-indol-3-yl](naftalen-1-yl)methanon | ||
| 5-API | 5-(2-aminopropyl)indol | ||
| APINACA | N-(adamantan-1-yl)-1-pentyl-1H-indazol-3-karboxamid | ||
| bk-PMA | 2-amino-1-(4-methoxyfenyl) propan-1-on | ||
| bk-PMMA | 1-(4-methoxyfenyl)-2-(methylamino)propan-1-on | ||
| 25B-NBOMe | 2-(4-brom-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin | ||
| Brolamfetamin | DOB | (2RS)-1-(4-brom-2,5-dimethoxyfenyl)propan-2-amin | |
| Bromo-Dragonfly | 1-(8-brombenzo[1,2-b:4,5-b']difuran-4-yl)propan-2-amin | ||
| Butylon | 2-(methylamino)-1-[3,4-(methylendioxy)fenyl)]butan-1-on | ||
| Joddimethoxyfenethylamin | 2C-I | (4-jod-2,5-dimethoxyfenethyl)amin | |
| 25C-NBOMe | 2-(4-chlor-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin | ||
| Dimethoxyethylthiofenethylamin | 2C-T-2 | [4-(ethylsulfanyl)-2,5-dimethoxyfenethyl]amin | |
| Dimethoxypropylthiofenethylamin | 2C-T-7 | [2,5-dimethoxy-4-(propylsulfanyl)fenethyl]amin | |
| CP-47,497 | 2-[(1R,3S)-3-hydroxycyklohexyl]-5-(2-methyloktan-2-yl)fenol | ||
| CRA-13 | (naftalen-1-yl)[4-(pentyloxy)naftalen-1-yl]methanon | ||
| DBZP | 1,4-dibenzylpiperazin | ||
| Diethyltryptamin | DET | N,N-diethyl-N-[2-(indol-3-yl)ethyl] amin | |
| Dimethoxyamfetamin | DMA | (2RS)-1-(2,5-dimethoxyfenyl)propan-2-amin | |
| 4,4'-DMAR | 4-methyl-5-(4-methylfenyl)-4,5-dihydro-1,3-oxazol-2-amin | ||
| Dimethylheptyltetrahydrokanabinol | DMHP | 3-(1,2-dimethylheptyl)-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol | |
| 3,4-DMMC | 1-(3,4-dimethylfenyl)-2-(methylamino)propan-1-on | ||
| Dimethyltriptamin | DMT | N-[2-(indol-3-yl)ethyl]-N,N-dimethylamin | |
| DOC | 1-(4-chlor-2,5-dimethoxyfenyl)propan-2-amin | ||
| Dimethoxyethylamfetamin | DOET | (2RS)-1-(4-ethyl-2,5-dimethoxyfenyl)propan-2-amin | |
| DOI | 1-(4-jod-2,5-dimethoxyfenyl)propan-2-amin | ||
| Eticyklidin | PCE | N-ethyl-1-fenylcyklohexylamin | |
| Etryptamin | 3-(2-aminobutyl)indol | ||
| 4-FA | 1-(4-fluorfenyl)propan-2-amin | ||
| 5F-AKB48 | N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-indazol-3-karboxamid | ||
| Flefedron | 1-(4-fluorfenyl)-2-(methylamino)propan-1-on | ||
| 4-FMA | 1-(4-fluorfenyl)-N-methylpropan-2-amin | ||
| 3-FMC | 1-(3-fluorfenyl)-2-(methylamino)propan-1-on | ||
| 5FUR-144 | [1-(5-fluorpentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyklopropyl)methanon | ||
| 25I-NBOMe | 2-(4-jod-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin | ||
| JWH-018 | (naftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-073 | (1-butyl-1H-indol-3-yl)(naftalen-1-yl)methanon | ||
| JWH-081 | (4-methoxynaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-122 | (4-methylnaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-200 | [1-(2-morfolinoethyl)-1H-indol-3-yl](naftalen-1-yl)methanon | ||
| JWH-250 | 2-(2-methoxyfenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-on | ||
| JWH-398 | (4-chlornaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| Kathinon | (2S)-2-amino-1-fenylpropan-1-on | ||
| (+)-Lysergid | LSD, LSD-25 | (+)-8β-(3,3-dimethylureido)-6-methyl-9,10-didehydroergolin | |
| 4-Metamfetamin | (2RS)-1-(4-methylfenyl)propan-2-amin | ||
| MBZP | 1-benzyl-4-methylpiperazin | ||
| mCPP | 1-(3-chlorfenyl)piperazin | ||
| MDAI | 5,6-(methylendioxy)indan-2-amin | ||
| MDPV | 1-[3,4-(methylendioxy)fenyl]-2-(pyrrolidin-1-yl)pentan-1-on | ||
| 3-MEC | 2-(ethylamino)-1-(3-methylfenyl)propan-1-on | ||
| 4-MEC | 2-(ethylamino)-1-(4-methylfenyl)-propan-1-on | ||
| Mefedron | 2-(methylamino)-1-(4-methylfenyl)propan-1-on | ||
| Meskalin | 3,4,5-trimethoxyfenethylamin | ||
| Methkathinon | Efedron | (2RS)-1-fenyl-2-(methylamino)propan-1-on | |
| 3-MMC | 2-(methylamino)-1-(3-methylfenyl)propan-1-on | ||
| Methoxytenamfetamin | MMDA | (2RS)-1-[5-methoxy-3,4-(methylendioxy)fenyl]propan-2-amin | |
| Methylaminorex | (±)-5-fenyl-4-methyl-4,5-dihydrooxazol-2-amin | ||
| Methyltenamfetamin | MDMA | (2RS)-N-methyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
| 3-MeO-PCP | 1-[1-(3-methoxyfenyl)cyklohexyl]piperidin | ||
| methoxetamine | 2-(ethylamino)-2-(3-methoxyfenyl)cyclohexanon | ||
| Methylon | 2-(methylamino)-1-[3,4-(methylendioxy)fenyl]propan-1-on | ||
| MT-45 | 1-cyklohexyl-4-(1,2-difenylethyl)-piperazin | ||
| Methylthioamfetamin | 4-MTA | (2RS)-1-[4-(methylsulfanyl)fenyl]propan-2-amin | |
| Nafyron | 1-(naftalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-on | ||
| Ethyltenamfetamin | MDE, MDEA | (2RS)-N-ethyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
| Hydroxytenamfetamin | (2RS)-N-hydroxy-1-[3,4-(methylendioxy)fenyl]propan-2-amin | ||
| Parahexyl | 3-hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol | ||
| pentedron | 1-fenyl-2-(methylamino)pentan-1-on | ||
| pFPP | 1-(4-fluorfenyl)piperazin | ||
| Methoxyamfetamin | PMA | (2RS)-1-(4-methoxyfenyl)propan-2-amin | |
| Methoxymetamfetamin | PMMA | 1-(4-methoxyfenyl)-N-methylpropan-2-amin | |
| Psilocybin | 3-[2-(dimethylamino)ethyl]-1H-indol-4-yl-dihydrogen-fosfát | ||
| Psilocin | Psilotsin | 3-[2-(dimethylamino)ethyl]-1H-indol-4-ol | |
| Rolicyklidin | PHP, PCPY | 1-(1-fenylcyklohexyl)pyrrolidin | |
| α-PVP | 1-fenyl-2-(pyrrolidin-1-yl)-1-pentan-1-on | ||
| Salvinorin A | methyl-(2RS,4aR,6aR,7R,9RS,10aRS,10bR)-9-acetoxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxododekahydro-1H-benzo[ƒ]isochromen-7-karboxylát | ||
| Dimethoxymetamfetamin | STP, DOM | (2RS)-1-(2,5-dimethoxy-4-methylfenyl)propan-2-amin | |
| Tenamfetamin | MDA | (2RS)-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
| Tenocyklidin | TCP | 1-[1-(2-thienyl)cyklohexyl]piperidin | |
| TFMPP | 1-[3-(trifluormethyl)fenyl]piperazin | ||
| Tetrahydrokanabinol | THC | Δ6a(10a)-, Δ6a(7)-, Δ7-, Δ8-, Δ10-, Δ9(11)-tetrahydrokanabinoly a jejich stereoizomery | |
| Trimethoxyamfetamin | TMA | (2RS)-1-(3,4,5-trimethoxyfenyl)propan-2-amin | |
| Trimethoxyamfetamin-2 | TMA-2 | (2RS)-1-(2,4,5-trimethoxyfenyl)propan-2-amin | |
| UR-144 | (1-pentyl-1H-indol-3-yl)-(2,2,3,3-tetramethylcyklopropyl)methanon |
Including stereoisomers of psychotropic substances, except for the explicit exceptions listed in this list in all cases where such stereoisomers may exist according to the specific chemical designation and salts of psychotropic substances listed in this list in all cases where they may exist. ';
This Regulation was notified in accordance with Directive 98 / 34 / EC of the European Parliament and of the Council of 22 June 1998 laying down a procedure for the provision of information in the field of technical standards and regulations and of rules on information society services, as amended.
Efficacy
This Regulation shall take effect on 1 October 2015.
Prime Minister:
Sobotka v. r.
Minister for Health:
MUDr.
Sign in for notes, favorites and notifications
Regulation Information
| Citation | Government Regulation No 243 / 2015 Coll., amending Government Regulation No 463 / 2013 Coll., on substance lists |
|---|---|
| Regulation Type | Regulation |
| Author | - |
| Collection | Code of Laws |
| Date of Promulgation | 30.09.2015 |
|---|---|
| Effective from | 01.10.2015 |
| Effective until | - |
| Status | Valid |
Legal Areas:
Administrative law
Health
The regulation text is for informational purposes only.
Comments 0